Evidence map›Paper›PMID 11696457›Full record

ArticleThe American journal of pathology2001

Exposure of mice to topical bovine thrombin induces systemic autoimmunity.

J G Schoenecker, R K Johnson, A P Lesher, J D Day, S D Love, M R Hoffman, T L Ortel, W Parker, J H Lawson

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Bovine thrombin and systemic autoimmunity.The American journal of pathology · 2003
    Article
  13. Immunological consequences of topical bovine thrombin.The American journal of pathology · 2001
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

J G SchoeneckerDepartment of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
R K Johnson
A P Lesher
J D Day
S D Love
M R Hoffman
T L Ortel
W Parker
J H Lawson
Duke Medical Center · USBipar · FRDuke University Hospital · USInstitute of Immunology · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bovine thrombin is used as an aid to hemostasis in medical and surgical procedures. At least 500,000 Americans are exposed to this therapeutic annually and reports suggest that exposure is associated with the development of autoreactive antibodies. To determine whether bovine thrombin can induce pathological autoimmunity we exposed nonautoimmune-prone galactose-alpha1-3-galactose-deficient mice to the two bovine thrombin preparations currently approved for use in the United States. We found that, like humans exposed to bovine thrombin, mice developed an immune response against the therapeutic and the xenogeneic carbohydrate galactose-alpha1-3-galactose, and some mice developed autoantibodies against clotting factors. Further, unexpectedly, a single exposure to this therapeutic also induced autoimmunity with features characteristic of systemic lupus erythematosus including antibodies against nuclear antigens, native DNA, double-stranded DNA, and cardiolipin. High levels of these autoantibodies correlated with glomerulonephritis in all mice evaluated. This autoimmune syndrome was detected in mice 15 weeks after a secondary exposure to bovine thrombin and female mice were found to develop the syndrome at a significantly greater frequency than males. Thus, these studies indicate that exposure to bovine thrombin preparations can induce a pathological systemic autoimmune syndrome with lupus-like serology.

Indexed as

Administration, TopicalAnimalsAntibodiesAntibodies, AnticardiolipinAntibodies, AntinuclearAutoantibodiesAutoimmune DiseasesAutoimmunityBehavior, AnimalCattleDNADNA, Single-StrandedFemaleGalactosyltransferasesMaleMiceAntibodiesAntibodies, AnticardiolipinAntibodies, AntinuclearAutoantibodiesDNADNA, Single-StrandedGalactosyltransferasesThrombin

Identifiers

PMID11696457
PMCPMC1867043
OpenAlexW2022462613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.